Cholesterol, not love, breaks these young hearts

AHMEDABAD: They are pushing late thirties, but their hearts might well be a decade older. They may seem thin and lean — not fitting the typical profile of a person with heart troubles. But cardiac arrest is an imminent threat for them.

Cholesterol, not love, breaks these young hearts
Dr Jayesh Prajapati, professor and head of the department of cardiology at UN Mehta Institute of Cardiology and Research Centre (UNICRC), said that cardiac problems are hitting younger people.

“The time bomb starts ticking right from the first decade of life when accumulation of fat results in fatty streaks in arteries,” Prajapati said. “In their twenties, it only needs a trigger provided by factors such as stress or bad lifestyle.” The plaque rupture results in clotting of blood inside arteries leading to sudden blockage, he said. “The result is uncontrollable vibration of heart which can end life in a matter of three to five minutes,” he said.

Dr Sibasis Sahoo, assistant professor at the UNICRC, said that compared to the older population, cardiac arrests thus become deadlier in the younger generation. “Our team had conducted a research of two groups of patients suffering from cardiovascular diseases —below and above 40 years of age,” Sahoo said. “Even when other factors such as body mass index and diabetes were similar, what made the stark difference was the cholesterol level.”

The study also pointed to the fact that majority of patients below 40 had a single vessel disease.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states

    All the Way from Teeth to Tee: Hole in One

    All the Way from Teeth to Tee: Hole in One

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Chemists strike on May 20: Reasons behind today’s all-India strike

    Chemists strike on May 20: Reasons behind today’s all-India strike

    AbbVie loses patent plea for Hep C drug

    AbbVie loses patent plea for Hep C drug